 | • レポートコード：MRC2305C153 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、229ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に180.3億ドルであった世界のハイスループットスクリーニング（HTS）市場規模が、2022年には203.7億ドルに成長し、その後年平均13.25％拡大して2027年には380.5億ドルに達すると予測しています。本調査資料では、ハイスループットスクリーニング（HTS）の世界市場について総合的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品＆サービス別（消耗品、器具、サービス、ソフトウェア）分析、技術別（細胞ベースアッセイ技術、ラボオンチップ（LOC）技術、ラベルフリー技術）分析、用途別（生化学的スクリーニング、創薬、ライフサイエンス研究）分析、エンドユーザー別（学術＆研究機関、受託研究機関（CRO）、製薬＆バイオテクノロジー企業）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめました。なお、本書内の企業情報には、Agilent Technologies, Inc.、Aurora Biomed Inc.、AXXAM S.p.A.、Beckman Coulter, Inc.、Bio-Rad Laboratories, Inc.、Biomat Srl、Biotek Instruments Inc.、BMG Labtech、Charles River Laboratories、Corning Incorporated、Danaher Corporation、Eurofins Scientificなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のハイスループットスクリーニング（HTS）市場規模：製品＆サービス別 - 消耗品の市場規模 - 器具の市場規模 - サービスの市場規模 - ソフトウェアの市場規模 ・世界のハイスループットスクリーニング（HTS）市場規模：技術別 - 細胞ベースアッセイ技術の市場規模 - ラボオンチップ（LOC）技術の市場規模 - ラベルフリー技術の市場規模 ・世界のハイスループットスクリーニング（HTS）市場規模：用途別 - 生化学的スクリーニングにおける市場規模 - 創薬における市場規模 - ライフサイエンス研究における市場規模 ・世界のハイスループットスクリーニング（HTS）市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 受託研究機関（CRO）における市場規模 - 製薬＆バイオテクノロジー企業における市場規模 ・世界のハイスループットスクリーニング（HTS）市場規模：地域別 - 南北アメリカのハイスループットスクリーニング（HTS）市場規模 アメリカのハイスループットスクリーニング（HTS）市場規模 カナダのハイスループットスクリーニング（HTS）市場規模 ブラジルのハイスループットスクリーニング（HTS）市場規模 ... - アジア太平洋のハイスループットスクリーニング（HTS）市場規模 日本のハイスループットスクリーニング（HTS）市場規模 中国のハイスループットスクリーニング（HTS）市場規模 インドのハイスループットスクリーニング（HTS）市場規模 韓国のハイスループットスクリーニング（HTS）市場規模 台湾のハイスループットスクリーニング（HTS）市場規模 ... - ヨーロッパ/中東/アフリカのハイスループットスクリーニング（HTS）市場規模 イギリスのハイスループットスクリーニング（HTS）市場規模 ドイツのハイスループットスクリーニング（HTS）市場規模 フランスのハイスループットスクリーニング（HTS）市場規模 ロシアのハイスループットスクリーニング（HTS）市場規模 ... - その他地域のハイスループットスクリーニング（HTS）市場規模 ・競争状況 ・企業情報 |
The Global High-Throughput Screening Market size was estimated at USD 18.03 billion in 2021 and expected to reach USD 20.37 billion in 2022, and is projected to grow at a CAGR 13.25% to reach USD 38.05 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the High-Throughput Screening to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product & Service, the market was studied across Consumables, Instruments, Services, and Software. The Consumables is further studied across Laboratory Equipment and Reagents & Assay Kits. The Instruments is further studied across Detection Systems and Liquid Handling Systems.
Based on Technology, the market was studied across Cell-based Assays, Lab-on-a-Chip Technology (LOC), and Label-free Technology. The Cell-based Assays is further studied across 2D Cell Culture, 3D Cell Culture, Perfusion Cell Culture, and Reporter-based Assays. The 3D Cell Culture is further studied across Scaffold-based Technology and Scaffold-free Technology. The Scaffold-based Technology is further studied across Hydrogels, Inert Matrix/Solid Scaffolds, and Micropatterned Surfaces. The Hydrogels is further studied across Alginate/Agarose, Animal-derived Hydrogels, and Synthetic Hydrogels. The Animal-derived Hydrogels is further studied across Collagen and Matrigel. The Scaffold-free Technology is further studied across Hanging-drop Plates and Ultra-low Binding Plates.
Based on Application, the market was studied across Biochemical Screening, Drug Discovery, and Life Sciences Research.
Based on End User, the market was studied across Academic & Research Institutes, Contract Research Organizations (CROs), and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for High-Throughput Screening market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the High-Throughput Screening Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global High-Throughput Screening Market, including Agilent Technologies, Inc., Aurora Biomed Inc., AXXAM S.p.A., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biomat Srl, Biotek Instruments Inc., BMG Labtech, Charles River Laboratories, Corning Incorporated, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche AG, Hamilton Company, Luminex Corporation, Merck KGaA, Molecular Devices, LLC., PerkinElmer, Inc., Promega Corporation, Reprocell Inc., Tecan Group Ltd., and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global High-Throughput Screening Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global High-Throughput Screening Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global High-Throughput Screening Market?
4. What is the competitive strategic window for opportunities in the Global High-Throughput Screening Market?
5. What are the technology trends and regulatory frameworks in the Global High-Throughput Screening Market?
6. What is the market share of the leading vendors in the Global High-Throughput Screening Market?
7. What modes and strategic moves are considered suitable for entering the Global High-Throughput Screening Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of open innovation models in pharmaceutical & biotechnology companies
5.1.1.2. Growing applications in stem cell research
5.1.1.3. Increasing R&D spending by pharmaceutical & biotechnology companies
5.1.2. Restraints
5.1.2.1. Capital-intensive nature of HTS instruments
5.1.3. Opportunities
5.1.3.1. Government funding and venture capital investments
5.1.3.2. Technological advancements in the HTS
5.1.4. Challenges
5.1.4.1. Dearth of skilled operators
5.2. Cumulative Impact of COVID-19
6. High-Throughput Screening Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3.1. Laboratory Equipment
6.3.2. Reagents & Assay Kits
6.3. Instruments
6.4.1. Detection Systems
6.4.2. Liquid Handling Systems
6.4. Services
6.5. Software
7. High-Throughput Screening Market, by Technology
7.1. Introduction
7.2. Cell-based Assays
7.3.1. 2D Cell Culture
7.3.2. 3D Cell Culture
7.3.3.1. Scaffold-based Technology
7.3.3.2.1. Hydrogels
7.3.3.2.2.1. Alginate/Agarose
7.3.3.2.2.2. Animal-derived Hydrogels
7.3.3.2.2.3.1. Collagen
7.3.3.2.2.3.2. Matrigel
7.3.3.2.2.3. Synthetic Hydrogels
7.3.3.2.2. Inert Matrix/Solid Scaffolds
7.3.3.2.3. Micropatterned Surfaces
7.3.3.2. Scaffold-free Technology
7.3.3.3.1. Hanging-drop Plates
7.3.3.3.2. Ultra-low Binding Plates
7.3.3. Perfusion Cell Culture
7.3.4. Reporter-based Assays
7.3. Lab-on-a-Chip Technology (LOC)
7.4. Label-free Technology
8. High-Throughput Screening Market, by Application
8.1. Introduction
8.2. Biochemical Screening
8.3. Drug Discovery
8.4. Life Sciences Research
9. High-Throughput Screening Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations (CROs)
9.4. Pharmaceutical & Biotechnology Companies
10. Americas High-Throughput Screening Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific High-Throughput Screening Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa High-Throughput Screening Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Aurora Biomed Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. AXXAM S.p.A.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Beckman Coulter, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Bio-Rad Laboratories, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Biomat Srl
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Biotek Instruments Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. BMG Labtech
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Charles River Laboratories
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Corning Incorporated
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Danaher Corporation
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Eurofins Scientific
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. F. Hoffmann-La Roche AG
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Hamilton Company
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Luminex Corporation
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Merck KGaA
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Molecular Devices, LLC.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. PerkinElmer, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Promega Corporation
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Reprocell Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Tecan Group Ltd.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Thermo Fisher Scientific Inc.
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing